Search results
In Worcester, hundreds of students and professors enjoy 'celestial Super Bowl' of eclipse
Worcester Telegram & Gazette via Yahoo News· 1 month agoWORCESTER ― The solar eclipse that dimmed the skies over Worcester Monday afternoon brought people...
Q3 2023 Mersana Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 months agoParticipants Brian C. DeSchuytner; Senior VP, CFO & COO; Mersana Therapeutics, Inc. Jason Fredette; SVP of IR & Corporate Communications; Mersana Therapeutics, Inc. Martin H. Huber; President ...
Revolution Crashes 34% On A Flop In Pancreatic Cancer Treatment. But There's A Silver Lining.
Investor's Business Daily· 7 months agoBiotech stock Revolution Medicines collapsed Monday after unveiling test results for an experimental...
Q4 2023 MacroGenics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 months agoParticipants Jim Karrels; SVP, CFO & Secretary; MacroGenics, Inc. Scott Koenig; President, CEO & Director; MacroGenics, Inc. Jonathan Chang; Analyst; Leerink Partners LLC Kelsey Goodwin; Analyst ...
Kura Makes Good On Its $150 Million Infusion And Shoots Up 12%
Investor's Business Daily· 4 months agoKura stock surged to a nearly three-year high Tuesday after Kura Oncology unveiled promising test...
Novocure Surges 12% On Brain Tumors Study; But Some Analysts Are Bearish
Investor's Business Daily· 2 months agoNovocure stock surged to its 50-day line on Wednesday after the company's medtech device nearly...
Q4 2023 Kura Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Pete De Spain; Executive Vice President of Investor Relations & Corporate Communications; Kura Oncology Inc Troy Wilson; President, CEO, Board Member; Kura Oncology Inc Tom Doyle ...
Q4 2023 Revolution Medicines Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Erin Graves; Head of Corporate Communications and Investor Relations; Revolution Medicines Inc Mark Goldsmith; President, CEO, Chairman; Revolution Medicines Inc Jack Anders; Chief ...
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Dips
Investor's Business Daily· 11 months agoImmunoGen and Day One Biopharmaceuticals unveiled promising cancer treatment updates over the...
Why Revolution Medicines Stock Is Crashing Today
Motley Fool· 7 months agoShares of Revolution Medicines (NASDAQ: RVMD) were crashing 42.5% lower as of 11:13 a.m. ET on Monday. The steep decline came after the oncology company...
